ADURO BIOTECH, INC. License Agreements
16 Contracts & Agreements
- SanReno License Agreement between the Registrant and SanReno Therapeutics Holdings Limited and SanReno Therapeutics (Hong Kong) Limited, a wholly owned subsidiary of SanReno... (Filed With SEC on March 17, 2022)
- License Agreement, dated December 16, 2019, by and between Chinook Therapeutics U.S., Inc. and AbbVie Ireland Unlimited Company (Filed With SEC on July 22, 2020)
- Amendment No. 3 to Exclusive License Agreement between Aduro Biotech, Inc. and the Memorial Sloan Kettering Cancer Center, dated March 30, 2020 (Filed With SEC on May 4, 2020)
- SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 1, 2017)
- AMENDMENT 1 TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 1, 2017)
- AMENDMENT TO RESEARCH AND LICENSE AGREEMENTS (Filed With SEC on March 8, 2016)
- EXCLUSIVE LICENSE AGREEMENT for INSTITUTIONS TECHNOLOGY Compositions & Methods for Altering Second Messenger Signaling Reference Numbers: Rutgers:L2015-0995_LFSC Rockefeller: RU... (Filed With SEC on March 11, 2015)
- EXCLUSIVE LICENSE BETWEEN ADURO BIOTECHINC AND THEREGENTS OF THE UNIVERSITY OF CALIFORNIA FOR CYCLIC-DI-NUCLEOTIDES THAT STIMULATE HUMAN STING VARIANTS AND STIMULATOR OFINTERFERON... (Filed With SEC on March 11, 2015)
- LICENSE AGREEMENT (Filed With SEC on March 11, 2015)
- RESTATED AND AMENDED LICENSE AGREEMENT (Filed With SEC on March 11, 2015)
- PATENT AND TECHNOLOGY LICENSE AND MATERIALS TRANSFER AGREEMENT BY AND BETWEEN THEJOHNS HOPKINS UNIVERSITY & ADURO BIOTECH, INC. JHU Agreement: # -A21083 PATENT AND TECHNOLOGY... (Filed With SEC on March 11, 2015)
- EXCLUSIVE LICENSE BETWEEN ADURO BIOTECHINC AND THEREGENTS OF THE UNIVERSITY OF CALIFORNIA FOR LISTERIA MONOCYTOGENES PHAGE INTEGRATION VECTOR (Filed With SEC on March 11, 2015)
- EXCLUSIVE LICENSE AGREEMENT BETWEEN THE JOHNSHOPKINS UNIVERSITY & ADURO BIOTECH JHUAgreement: # -A19340 LICENSE AGREEMENT (Filed With SEC on March 11, 2015)
- CONFIDENTIAL RESEARCH AND LICENSE AGREEMENT between Janssen Biotech, Inc. and Aduro Biotech,Inc. Executed as of October 13, 2014 CONFIDENTIAL (Filed With SEC on March 11, 2015)
- CONFIDENTIAL GVAX PROSTATE LICENSE AGREEMENT between Janssen Biotech,Inc. and AduroBiotech, Inc. May 27, 2014 CONFIDENTIAL (Filed With SEC on March 11, 2015)
- CONFIDENTIAL RESEARCH AND LICENSE AGREEMENT between Janssen Biotech, Inc. and Aduro Biotech,Inc. May 27, 2014 (Filed With SEC on March 11, 2015)
